BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19886182)

  • 21. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
    Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
    El-Zammar OA; Zhang S; Katzenstein AL
    Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-diagnostic aspects and therapeutic considerations of the combined surgical and radiotherapeutic approach in 2 cases of sacrococcygeal chordoma: our experience].
    Zoppi S; Maritato F; Pavero R; Costanzo A; Cariati A; Maritato P; Serafino G; Casano A; Biggi S; Prandi M; Terrizzi A; Valleriani M; Fornaro R
    G Chir; 1997 Mar; 18(3):107-10. PubMed ID: 9206489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
    Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
    Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
    Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
    Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable.
    Moojen WA; Vleggeert-Lankamp CL; Krol AD; Dijkstra SP
    Spine (Phila Pa 1976); 2011 May; 36(10):E656-61. PubMed ID: 21217422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
    Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign notochordal cell tumour: clinicopathology and molecular profiling of 13 cases.
    Du J; Xu L; Cui Y; Liu Z; Su Y; Li G
    J Clin Pathol; 2019 Jan; 72(1):66-74. PubMed ID: 30355586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG; Steiniche T; Overgaard J;
    Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number.
    Kim MA; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
    Histopathology; 2008 May; 52(6):738-46. PubMed ID: 18397279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma.
    Deshpande V; Nielsen GP; Rosenthal DI; Rosenberg AE
    Am J Surg Pathol; 2007 Oct; 31(10):1573-7. PubMed ID: 17895760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment and prognosis of sacrococcygeal chordoma--study of bone tumor registry in Japan].
    Osaka S; Toriyama S
    Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):240-4. PubMed ID: 2738424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
    Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
    Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
    Piris A; Scopsi L; Clemente C; Cetti Serbelloni F; Mihm MC; Hoang MP
    Am J Dermatopathol; 2010 Aug; 32(6):586-92. PubMed ID: 20534988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.
    Gilbert JA; Adhikari LJ; Lloyd RV; Rubin J; Haluska P; Carboni JM; Gottardis MM; Ames MM
    Endocr Relat Cancer; 2010 Sep; 17(3):623-36. PubMed ID: 20385747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions.
    Yamaguchi T; Yamato M; Saotome K
    Skeletal Radiol; 2002 Jul; 31(7):413-8. PubMed ID: 12107574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.